VBWG
Monograph

Vascular Biology in Clinical Practice © Vol. 4, No. 4

• Anticoagulant therapy in the PCI patient

This monograph, Anticoagulant therapy in the PCI patient, is intended to explore the role of anticoagulant therapy in patients scheduled for percutaneous coronary intervention, particularly as it is evolving in regard to other components of antithrombotic therapy (i.e. antiplatelet therapy with aspirin and/or thienopyridines). Topics covered include mechanism of thrombus formation, pharmacology of different classes of anticoagulant agents, and relevant clinical studies.
Carl J. Pepine, MD, University of Florida College of Medicine is editor in chief.




CME_Monograph.pdf (0.8MB)CME_Monograph.pdf (0.8MB)


AnticoagulantantithromboticbiologycomponentscoronaryevolvingexploremonographparticularlyPCIpercutaneousscheduledvascularVol

Related at vwbg.org

Vascular Biology in Clinical Practice TM Vol. 7, No. 2

New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy

This monograph, New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 3

A HOPE FOR PEACE? Update on the role of ACE inhibition in CAD patients

This monograph, A HOPE for PEACE? Update on the role of ACE inhibition in CAD patients , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.
More related